Bank of America’s Epizyme, Inc EPZM Stock Holding History

Bank of America’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-5,700	Closed	-$62K	–	7961
2020 Q4	$62K	Hold	5,700	–	–	﹤0.01%	6237
2020 Q3	$68K	Buy	+5,700	New	+$76.3K	﹤0.01%	5875
2017 Q4	–	Sell	-50,000	Closed	-$953K	–	7349
2017 Q3	$953K	Hold	50,000	–	–	﹤0.01%	4544
2017 Q2	$755K	Buy	+50,000	New	+$756K	﹤0.01%	4618

Other funds holding EPZM

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Bank of America's EPZM Position: Q3 2022 in Review

Bank of America sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 160 shares.

Bank of America first reported a position in EPZM in Q2 2013 and held it in 36 quarters. The position peaked at $7.39M in Q4 2021. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.

Bank of America reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
Bank of America sold 160 Epizyme, Inc shares in Q3 2022.
Bank of America first reported a position in Epizyme, Inc in Q2 2013 and held it in 36 quarters.
Bank of America's Epizyme, Inc position peaked at $7.39M in Q4 2021.
0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.

Based on Bank of America's 13F filing for Q3 2022, filed 14 Nov 2022.